☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
opioid induced constipation
RedHill Replaces its Co-Commercialization Agreement with Daiichi Sankyo for Movantik (naloxegol)
August 4, 2020
BioDelivery Sciences (BDSI) Signs a License Agreement with Shionogi to Commercialize Symproic (naldemedine) in the US
April 11, 2019
Load more...
Back to Home
